Insider · CIK 0001984252
Mary Beth Schulte
Files at ABX (Abacus Life, Inc.). First filing -, latest -.
In brief
Mary Beth Schulte files SEC Form 4 as director at ABX (Abacus Life, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mary Beth Schulte has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | ABX Abacus Life, Inc. | AGrant or award Common Stock | +20,792 | $10.10 | $210k | 55,070 | Mar 16, 2026 |
| Apr 2, 2025 | ABX Abacus Life, Inc. | AGrant or award Common Stock | +12,278 | $0.00 | $0 | 34,278 | Apr 3, 2025 |
| Nov 9, 2023 | ABX Abacus Life, Inc. | AGrant or award Common Stock | +9,000 | $0.00 | $0 | 22,000 | Nov 13, 2023 |
Questions about Mary Beth Schulte
Answered from the filings on this page, as of the latest one.
Is Mary Beth Schulte buying or selling?
Mary Beth Schulte has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mary Beth Schulte's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mary Beth Schulte has 0.
Where does Mary Beth Schulte file Form 4?
Mary Beth Schulte has filed Form 4 at ABX (Abacus Life, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.